The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 08, 2012
Filed:
Jan. 21, 2009
Nucleic acid and corresponding protein entitled 213p1f11 useful in treatment and detection of cancer
Pia M. Challita-eid, Encino, CA (US);
Arthur B. Raitano, Los Angeles, CA (US);
Mary Faris, Los Angeles, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Robert Kendall Morrison, Santa Monica, CA (US);
Wangmao GE, Los Angeles, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Pia M. Challita-Eid, Encino, CA (US);
Arthur B. Raitano, Los Angeles, CA (US);
Mary Faris, Los Angeles, CA (US);
Rene S. Hubert, Los Angeles, CA (US);
Robert Kendall Morrison, Santa Monica, CA (US);
Wangmao Ge, Los Angeles, CA (US);
Aya Jakobovits, Beverly Hills, CA (US);
Agensys, Inc., Santa Monica, CA (US);
Abstract
A novel gene (designated 213P1F11) and its encoded protein, and variants thereof, are described wherein 213P1F11 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 213P1F11 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 213P1F11 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization.